Forte Biosciences, Inc.
FBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $93,414 | $106,144 | $45,856 | $22,244 |
| Short-Term Investments | $0 | $0 | $0 | $36,121 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,998 | $1,472 | $1,302 | $2,981 |
| Total Curr. Assets | $95,412 | $107,616 | $47,158 | $61,346 |
| Property Plant & Equip (Net) | $148 | $110 | $125 | $77 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,529 | $57 | $176 | $138 |
| Total NC Assets | $1,677 | $167 | $301 | $215 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $97,089 | $107,783 | $47,459 | $61,561 |
| Liabilities | – | – | – | – |
| Payables | $5,491 | $5,301 | $5,023 | $4,879 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7,501 | $3,869 | $4,009 | $4,202 |
| Total Curr. Liab. | $12,992 | $9,170 | $9,032 | $9,081 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $12,992 | $9,170 | $9,032 | $9,081 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13 | $12 | $6 | $6 |
| Retained Earnings | -$198,585 | -$180,903 | -$169,654 | -$153,998 |
| AOCI | -$6 | $0 | $0 | $11 |
| Other Equity | $282,675 | $279,504 | $208,075 | $206,461 |
| Total Equity | $84,097 | $98,613 | $38,427 | $52,480 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $97,089 | $107,783 | $47,459 | $61,561 |
| Net Debt | -$93,414 | -$106,144 | -$45,856 | -$22,244 |